“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says
In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco
NCI To Lose 19% of Workforce Over Six Years, Broder Says
NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion
NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes
Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines
Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines
DCPC To Merge Two Programs, Reorganizes Chemoprevention
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”
